6,771 results match your criteria: "Menorrhagia"

Objective: Hematologic malignancies in women of reproductive age carry significant additional morbidity due to menstrual bleeding in conjunction with disease and treatment-associated cytopenias. Several agents for menses prophylaxis and suppression exist, but there is a paucity of data comparing these therapies, particularly in the cancer setting.

Data Sources: A thorough literature review and evaluation of available data was conducted via PubMed search and combined with clinical expertise.

View Article and Find Full Text PDF

Objective: To study the role of PGE in regulating plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator (tPA) in human primary endometrial endothelial cells (HEECs) from women with normal menstrual bleeding (NMB) and heavy menstrual bleeding (HMB).

Design: In vitro study using endometrial endothelial cells.

Setting: Research laboratory setting.

View Article and Find Full Text PDF
Article Synopsis
  • * A total of 485 women with diagnosed thyroid dysfunction and 108 healthy controls were studied, focusing on various menstrual issues like hypermenorrhea and amenorrhea.
  • * Results showed that hypermenorrhea was notably more common in those with overt hypothyroidism compared to controls, while hyperthyroid patients didn't show significant differences in menstrual disorders compared to healthy individuals.
View Article and Find Full Text PDF
Article Synopsis
  • * A study analyzed data from 67 women treated at a clinic, finding that 80% needed both hormonal therapy and tranexamic acid to manage HMB, resulting in a 64% improvement in bleeding scores within the first year.
  • * Long-term follow-up showed continued improvement in blood loss management over five years, though 20% experienced a relapse of symptoms, particularly due to non-compliance and concerns about hormonal treatment side effects.
View Article and Find Full Text PDF

Background: Fumarate hydratase (FH)-deficient (FH-d) leiomyomas are included in the recent World Health Organization fascicle of the female genital tumors. These are known to be associated with hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome. The tumors can be diagnosed based on certain histopathological features, along with loss of immunohistochemical expression of FH immunostain in most tumors.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on the link between leukocyte telomere length (LTL) and various female reproductive endocrine diseases, using Mendelian randomization (MR) to explore genetic associations.
  • Data were sourced from extensive genetic studies involving large sample sizes, specifically utilizing the UK Biobank and the FinnGen consortium to analyze conditions like menorrhagia and endometriosis.
  • Results suggested that longer LTL is significantly associated with an increased risk of menorrhagia, indicating a potential genetic connection that warrants further investigation.
View Article and Find Full Text PDF

Assessing the impact of hormonal contraceptive use on menstrual health among women of reproductive age - a systematic review.

Eur J Contracept Reprod Health Care

October 2024

Department of Sexual and Reproductive Health and Research, World Health Organization, Geneva, Switzerland.

Background: Contraceptive methods are well-established in their ability to prevent pregnancy and increase individual agency in childbearing. Evidence suggests that contraceptives can also be used to treat adverse conditions associated with menstruation, including abnormal and prolonged uterine bleeding, heavy menstrual bleeding, painful menstruation, endometriosis, uterine fibroids, and premenstrual dysphoric disorders.This review investigates the effects of contraceptive techniques such as contraceptive pills, and long-acting reversible contraceptives (e.

View Article and Find Full Text PDF

Objective: Identification of heavy menstrual bleeding (HMB) cases in primary care settings is often done by using pictorial blood assessment charts (PBAC). The study aims to highlight the challenge of assessing blood loss, to develop a standardized method to efficiently customize a patient-reported pictorial chart, to validate the tool produced with our proposed method, and to demonstrate the feasibility of using PBACs in settings where resources are scarce.

Materials And Methods: Using blood samples and feedback from 21 women aged 30-51 years, we followed guidelines suggested in the literature, developed a method to produce PBACs for regular, long and night sizes, and had 9 participants testuse them.

View Article and Find Full Text PDF

Effectiveness of high-intensity focused ultrasound combined with gonadotropin-releasing hormone agonist or combined with levonorgestrel-releasing intrauterine system for adenomyosis: A systematic review and meta-analysis.

Taiwan J Obstet Gynecol

July 2024

Department of Obstetrics and Gynecology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC; Department of Obstetrics and Gynecology, Kang Ning Hospital, Neihu, Taipei, Taiwan, ROC. Electronic address:

Gonadotropin-Releasing Hormone Agonist (GnRH-a) and levonorgestrel releasing intrauterine system (LNG-IUS) are conventional conservative treatments for adenomyosis, and high-intensity focused ultrasound (HIFU) is a novel ablation technique. This study aimed to investigate the effectiveness of HIFU combined with GnRH-a or LNG-IUS for adenomyosis patients. In this systematic review and meta-analysis, Pubmed, Embase, Cochrane Library and Scopus databases were searched up to December 2021.

View Article and Find Full Text PDF

Introduction And Importance: Endometriosis is a prevalent condition within the female reproductive age group, but its presentation and diagnosis still pose a challenge as it mimics other diseases and affects multiple organ systems.

Case Presentation: A 24-year-old nulliparous female presented with complaints of menorrhagia, lower abdominal pain, post-coital bleeding, and significant weight loss for 7 months.

Clinical Discussion: The case highlights the challenge of diagnosing endometriosis due to its ability to mimic other conditions, such as carcinoma cervix and rectum.

View Article and Find Full Text PDF

Association Between Intrauterine System Hormone Dosage and Depression Risk.

Am J Psychiatry

September 2024

Neurobiology Research Unit (Larsen, Ozenne, Frokjaer) and Department of Gynecology, Fertility, and Obstetrics, Juliane Marie Center (Mikkelsen, Lidegaard), Copenhagen University Hospital, Rigshospitalet, Copenhagen; Department of Clinical Medicine (Larsen, Lidegaard, Frokjaer) and Department of Public Health, Section of Biostatistics (Ozenne), University of Copenhagen, Copenhagen; Department of Gynecology and Obstetrics, Copenhagen University Hospital, Herlev and Gentofte Hospital, Herlev, Denmark (Mikkelsen); Psychiatric Research Unit, Department of Clinical Research, University of Southern Denmark, Odense (Munk-Olsen); National Center for Register-Based Research, Aarhus University, Aarhus, Denmark (Munk-Olsen); Psychiatric Center Copenhagen, Mental Health Services in the Capital Region of Denmark, Copenhagen (Frokjaer).

Objective: The authors compared the associated risk of incident depression between first-time users of low-, medium-, and high-dose levonorgestrel-releasing intrauterine systems (LNG-IUSs).

Methods: This national cohort study was based on Danish register data on first-time users of LNG-IUSs, 15-44 years of age, between 2000 and 2022. Cox regression and a G-formula estimator were used to report 1-year average absolute risks, risk differences, and risk ratios of incident depression, defined as initiation of an antidepressant or receipt of a depression diagnosis, standardized for calendar year, age, education level, parental history of mental disorders, endometriosis, menorrhagia, polycystic ovary syndrome, dysmenorrhea, leiomyoma, and postpartum initiation.

View Article and Find Full Text PDF

CD8-positive T-cell lymphoproliferative disorder of the uterus: a new subtype of indolent extranodal T-cell neoplasm?

J Hematop

September 2024

Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN, USA.

A 51-year-old female with menorrhagia was found to have a cervical polyp. Polypectomy and endometrial curettage showed an atypical lymphoid infiltrate. Hysterectomy was performed, showing extensive myometrial infiltration by small, cytologically bland CD3-positive αβ T cells with a non-activated cytotoxic phenotype and a low proliferative rate.

View Article and Find Full Text PDF

To investigate the clinicopathological features, diagnosis, surgical treatment and prognosis of uterine tumors similar to ovarian sex cord tumors (UTROSCT). The clinical data, surgical approach, histopathological, and immunohistochemical features of 7 cases of UTROSCTs were retrospectively reviewed and followed up. All 4 patients were premenopausal women.

View Article and Find Full Text PDF

Bloody stressed! A systematic review of the associations between adulthood psychological stress and menstrual cycle irregularity.

Neurosci Biobehav Rev

August 2024

Cerebro Vascular Accidents and Behavioural Recovery Laboratory, School of Psychology, University of Ottawa, Ottawa, Canada. Electronic address:

Regular menstruation is a key indicator of general health and irregular menstrual parameters have been associated with elevated risk of adverse health outcomes. While psychological stress is believed to contribute to abnormal menstruation, little is known of the effects of discrete psychological stressors, including the COVID-19 pandemic, on menstrual function. A systematic database search was performed and studies investigating the relation between psychological stress and menstrual cycle irregularity in otherwise healthy adults were included.

View Article and Find Full Text PDF
Article Synopsis
  • * The research included 48 women who underwent UAE, showing that over time, 60.4% had reduced dysmenorrhoea and 85.7% had improved menorrhagia, with low recurrence rates.
  • * The effectiveness of UAE is linked to a specific imaging volume measured post-surgery, suggesting that certain MRI results can help predict how much a patient might improve after the procedure.
View Article and Find Full Text PDF
Article Synopsis
  • Two clinical trials focused on the effectiveness of relugolix combination therapy for women experiencing heavy menstrual bleeding due to uterine fibroids.
  • Participants self-reported their symptoms and quality of life before, during, and after a 24-week treatment with either relugolix or a placebo.
  • Results indicated that women using relugolix reported reduced distress from fibroid symptoms and an overall improvement in their health-related quality of life compared to those on the placebo.
View Article and Find Full Text PDF

Background: Thomas Cullen described bleeding abnormalities and dysmenorrhea as the "expected" presentations of adenomyomas. Adenomyosis is included within the FIGO classification of structural causes of abnormal uterine bleeding (AUB). Nevertheless, this long-standing association has been questioned by some authors who reported a high incidence of adenomyosis in uteri removed for indications other than AUB or dysmenorrhea.

View Article and Find Full Text PDF
Article Synopsis
  • - Paragangliomas (PGL), including urinary bladder paragangliomas (UBPGL), are rare tumors from the autonomic nervous system, with UBPGL making up only 0.7% of PGL and less than 0.05% of bladder tumors.
  • - A case presented a 42-year-old woman with symptoms like menorrhagia and hematuria, who was diagnosed with a UBPGL and a potential myxoma in her heart; a novel mutation linked to the UBPGL was identified as somatic and predicted to impact function.
  • - The report emphasizes the difficulty in diagnosing UBPGLs and shows the importance of a multidisciplinary approach, along with the necessity of
View Article and Find Full Text PDF

: Adenomyosis is a benign condition characterized by the presence of endometrial tissue within the myometrium. Despite surgery being a valuable approach, medical options are considered as the first-line approach and have been investigated in the treatment of adenomyosis, although strong evidence in favor of these is still lacking. This study aims to gather all available data and determine the effectiveness of the aforementioned medical options in patients with associated pain and not currently seeking pregnancy, both in comparison to placebo and to one another.

View Article and Find Full Text PDF

Menstrual blood loss is an independent determinant of hemoglobin and ferritin levels in premenopausal blood donors.

Acta Obstet Gynecol Scand

August 2024

Donor Studies, Department of Donor Medicine Research, Sanquin Research, Amsterdam, the Netherlands.

Introduction: To prevent blood donors from developing iron deficiency (ferritin <15 μg/L) and subsequent anemia (hemoglobin <120 g/L), blood services rely on information about known risk factors, including the donor's sex and age. For example, while Finnish women are able to donate whole blood with a minimum donation interval of 91 days, women in the 18 to 25-year-old age group are recommended to donate no more than once per year. Menstrual blood loss is not accounted for in blood donation interval recommendations, despite being a known risk factor of iron deficiency.

View Article and Find Full Text PDF

[Not Available].

Ugeskr Laeger

May 2024

Gynækologisk-Obstetrisk Afdeling, Slagelse Sygehus.

This is a case report of a 44-year-old premenopausal woman who was admitted to hospital due to uncontrollable and life-threatening vaginal bleeding after starting rivaroxaban treatment for atrial fibrillation. She had a medical history with menorrhagia due to an intrauterine fibroma. She did not respond sufficiently to factor X supplement or other non-surgical medical interventions.

View Article and Find Full Text PDF

Introduction: Fallopian tube cancer is a rare tumor, representing between 0.3 and 1.8 % of all malignant tumors in the gynecological sphere.

View Article and Find Full Text PDF

Perioperative complications in women undergoing thermal balloon endometrial ablation after one or more cesarean deliveries.

Eur J Obstet Gynecol Reprod Biol

August 2024

Department of Gynecology, Obstetrics and Gynecological Endocrinology, Kepler University Hospital, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz and Krankenhausstrasse 9, 4020 Linz, Austria.

Objective: To determine whether thermal ballon endometrial ablation can be safely performed after one or more cesarean sections.

Study Design: Retrospective cohort study including all women who underwent thermal balloon endometrial ablation at the Kepler University Hospital, Austria, between November 2017 and December 2022. For the analysis of the study endpoints, the dataset was divided into two groups: women with at least one cesarean section, and women without a history of cesarean section.

View Article and Find Full Text PDF

What Is This Summary About?: This summary describes what researchers learned during interviews of women with uterine fibroids and heavy menstrual bleeding (or period bleeding). At this time, little is known about how women perceive the impact of uterine fibroids on their lives and more information is needed. The goal of this study was to provide new information about the symptoms women have and how these symptoms affect their everyday lives.

View Article and Find Full Text PDF